Stock Research for AVMXY

AVMXY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AVMXY Stock Chart & Research Data

The AVMXY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AVMXY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AVMXY Due diligence Resources & Stock Charts

The AVMXY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AVMXY Detailed Price Forecast - CNN Money CNN View AVMXY Detailed Summary - Google Finance
Yahoo View AVMXY Detailed Summary - Yahoo! Finance Zacks View AVMXY Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AVMXY Trends & Analysis - Trade-Ideas Barrons View AVMXY Major Holders - Barrons
NASDAQ View AVMXY Call Transcripts - NASDAQ Seeking View AVMXY Breaking News & Analysis - Seeking Alpha
Spotlight View AVMXY Annual Report - CompanySpotlight.com OTC Report View AVMXY OTC Short Report - OTCShortReport.com
TradeKing View AVMXY Fundamentals - TradeKing Charts View AVMXY SEC Filings - Bar Chart
WSJ View Historical Prices for AVMXY - The WSJ Morningstar View Performance/Total Return for AVMXY - Morningstar
MarketWatch View the Analyst Estimates for AVMXY - MarketWatch CNBC View the Earnings History for AVMXY - CNBC
StockMarketWatch View the AVMXY Earnings - StockMarketWatch MacroAxis View AVMXY Buy or Sell Recommendations - MacroAxis
Bullish View the AVMXY Bullish Patterns - American Bulls Short Pains View AVMXY Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AVMXY Stock Mentions - StockTwits PennyStocks View AVMXY Stock Mentions - PennyStockTweets
Twitter View AVMXY Stock Mentions - Twitter Invest Hub View AVMXY Investment Forum News - Investor Hub
Yahoo View AVMXY Stock Mentions - Yahoo! Message Board Seeking Alpha View AVMXY Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AVMXY - SECform4.com Insider Cow View Insider Transactions for AVMXY - Insider Cow
CNBC View AVMXY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AVMXY - OTC Markets
Yahoo View Insider Transactions for AVMXY - Yahoo! Finance NASDAQ View Institutional Holdings for AVMXY - NASDAQ


Stock Charts

FinViz View AVMXY Stock Insight & Charts - FinViz.com StockCharts View AVMXY Investment Charts - StockCharts.com
BarChart View AVMXY Stock Overview & Charts - BarChart Trading View View AVMXY User Generated Charts - Trading View




Latest Financial News for AVMXY


AVITA Medical Announces Receipt of A$1.4 Million Research and Development Tax Credit
Posted on Monday December 17, 2018

AVITA Medical , a global regenerative medicine company, today announced that it has received a Research and Development Tax Incentive cash rebate from the Australian Tax Office in the amount of A$1,421,000 for the year ending 30 June 2018.


AVITA Medical Announces Institutional Placement of A$40.0 Million to Support Commercialization and Pipeline Advancement
Posted on Monday December 03, 2018

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced an institutional placement of A$40.0 million (Institutional Placement) to fund the marketing and sales effort to support U.S. market launch of the RECELL® System, clinical and research and development to facilitate pipeline advancement, and general working capital requirements. Avita has received under the Institutional Placement commitments from U.S., Australian and international institutional and sophisticated investors for a placement of A$40.0 million at an issue price of A$0.080 per share, with the placement to occur in two tranches. Tranche 1 of the institutional placement, totaling A$24.5 million, is expected to settle on 7 December 2018 without the need for prior shareholder approval.


AVITA Medical Announces Hiring of Full U.S. Sales Team of Experienced Burn Professionals to Support National Launch of RECELL® System
Posted on Thursday November 15, 2018

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that it has completed hiring of the U.S. sales team to support the U.S. market launch of the RECELL® System for the treatment of acute thermal burns. The full direct sales team of 20 healthcare professionals has joined AVITA and are in the process of completing a rigorous training program, including on-site training within burn centers, in preparation for the market launch of the RECELL System.


Leading Burn Surgeons Present Positive RECELL® System Results at 31st Annual Southern Region Burn CME Conference and Northeast Region Burn Conference
Posted on Monday November 12, 2018

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that key opinion leaders from five U.S. burn centers presented clinical results of the RECELL® Autologous Cell Harvesting Device (RECELL® System) at two U.S. burn conferences, the 31st Annual Southern Region Burn CME Conference held in Mobile, AL and the Northeast Region Burn Conference held in Cambridge, MA. In addition, the burn surgeons led two medical education symposiums on the use of the RECELL System at the conferences.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.